Abstract
Obesity and diabetes mellitus type 2 are associated with an increased risk of colorectal cancer. Recent studies have suggested beneficial effects of metformin in patients with cancer and diabetes. We sought to investigate the impact of metformin on recurrence and survival in a large, pooled analysis of non-metastatic colon cancer (CC) patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
